L
eptin is an adipocyte-derived hormone initially described for its profound effects on energy balance, 1 which are largely mediated via leptin receptors expressed on cells in the hypothalamus. 2 Leptin receptors have also been shown to be expressed on other cell types that may affect vascular disease processes including white blood cells, 3 platelets, 4 endothelial cells, 5 and vascular smooth muscle cells (VSMCs). 6 These receptor pools are likely to be biologically relevant as leptin has been demonstrated to promote angiogenesis, 7 thrombosis, 8 -10 atherosclerosis, 9 and neointimal hyperplasia 11, 12 in animal models. However, the relevant leptin receptor pools responsible for these vascular effects are unclear.
The interaction of leptin at the leptin receptor results in the phosphorylation of critical tyrosine residues 13 and subsequent activation of additional intracellular signaling. Several pathways have been implicated in post-leptin receptor signaling events toward appetite and metabolism including PI3 kinase, 14 AMP kinase, 15 and signal transducer and activator of transcription 3 (STAT3). 16 Tyr1138 of the leptin receptor mediates activation of STAT3. Substitution of Tyr1138 with serine blocks STAT3 activation in cultured cells and in mice in which the leptin receptor is replaced by this mutant (lepr s/s ). 16 The obesity of these lepr s/s mice closely resembles that of leptin receptor-deficient (lepr db/db ) mice. 16 However, the role of this pathway in mediating leptin receptor responses on vascular phenotypes in vivo is unknown.
This report examines the effects of leptin and leptin deficiency on neointimal hyperplasia after vascular injury. We demonstrate that the in vivo effect of leptin is not mediated by bone marrow-derived elements, is at least partially independent of leptin receptor-mediated STAT3 signaling, and is associated with the proliferation of vascular smooth muscle cells.
Methods Mice
Wild-type (wt), leptin-deficient (lep ob/ob ), and leptin receptor-deficient (lepr db/db ) mice were purchased from the Jackson Laboratory (Bar Harbor, Me). Targeted leptin receptor mutant mice with failure to activate STAT3 signaling pathways (lepr s/s ) were generated as previously described. 16 Lepr s/s mice had been backcrossed to the C57BL/6J strain Ն7 generations. Male animals, between 8 and 11 weeks of age, were fed a standard laboratory rodent diet (#5001, TestDiet, Richmond, Ind) in specific pathogen-free facilities. All procedures complied with the Principles of Laboratory and Animal Care established by the National Society for Medical Research and were approved by the University of Michigan Committee on Use and Care of Animals.
Femoral Artery Injury
Mouse femoral artery injury was performed using a model of wire-induced vascular injury as described previously. 17 This model causes endothelial damage at the site of injury followed by reproducible intimal hyperplasia. Mice were anesthetized with intraperitoneal sodium pentobarbital (120 mg/kg; Butler Co), except for mice that received a BMT, which were anesthetized with inhaled isofluorane (Baxter Healthare Corporation) using a Veterinary Anesthesia and Monitoring device (SurgiVet Inc). Mice were then secured in the supine position and placed under a dissecting microscope (Nikon SMZ-2T, Mager Scientific Inc). After a midline incision was made on the ventral left thigh region, the femoral nerve was isolated and pulled aside. The distal and proximal ends of the femoral artery were held with surgical suture for temporary control of blood flow. A small arterial branch superior to the muscular branch of the femoral artery was cauterized (DELC Cauterizer, Aaron Medical Industries Inc). One drop of 1% lidocaine was used to prevent arterial spasm. An arteriotomy of the femoral artery muscular branch was then performed. A straight guide wire (0.38 mm diameter, No. C-SF-15-15, Cook) was introduced 1 cm into the femoral artery through this muscular branch and remained in the artery for 1 minute. After the wire was removed, the muscular branch was ligated with 7.0 silk suture. Blood flow through the femoral artery was restored by releasing the surgical thread. Surgical clips were used to close the incision site.
Leptin Replacement
Recombinant murine leptin (R&D Systems) was delivered to mice via intraperitoneal (IP) injection (5.0 g/g body weight). Adenovirus expressing murine leptin on the RSV promoter (ad-leptin; gift of Dr Savio Woo, Mount Sinai, New York) 18 was delivered to mice via tail vein injection (1.25ϫ10 11 pfu/mouse). A control empty adenoviral vector was delivered to lep ob/ob via the same conditions.
Bone Marrow Transplantation
At 10 weeks of age, wt and lepr db/db mice were irradiated and bone marrow transplantation (BMT) was performed as previously described. 8 We have previously shown that this protocol leads to complete engraftment. 8 Femoral artery injury was performed six weeks following transplantation.
Histological and Morphometric Analyses
At the end of the protocol, mice were injected with bromodeoxyuridine (BrdU; Zymed Laboratories Inc) (IP, 30 g/g body weight) 12 and 2 hours before sacrifice. The mice were perfused with saline and fixed using formalin with a 25 gauge needle, inserted into the left ventricle, at a rate of 1 mL/min. The injured femoral artery was excised, embedded in paraffin blocks, sectioned (5um), and stained for elastin using the Accustain Elastic Stain kit (Sigma-Aldrich). For quantitation, 4 cross sections taken every 2 mm were selected from each artery. The images were analyzed using Image-Pro Plus software (Media Cybernetics). Intimal (I) and medial (M) areas were measured and the ratio of I/M was calculated. Immunohistochemistry was performed as described previously. 19 Smooth muscle cells were detected by smooth muscle ␣-actin staining using an ␣-actin monoclonal antibody (1:100, Cedarlane Laboratories Limited). Cellular proliferation was analyzed with BrdU Staining Kit (Zymed Laboratories Inc) and the number of BrdU-positive cells were counted manually and expressed as BrdU-positive nuclei within the external elastic lamina per cross section.
Body Weight, Metabolic Parameters, and Blood Pressure
Mouse body weight was recorded weekly after arterial injury. At the time of euthanasia, blood was obtained by ventricular puncture for plasma separation. Plasma concentration of cholesterol, triglycerides, glucose (Sigma-Aldrich), and insulin (Crystal Chemical Inc) were determined at the time of sacrifice. Plasma leptin levels were determined weekly after arterial injury using a murine leptin ELISA kit (Crystal Chemical Inc). Arterial blood pressure was determined in 8-to 10-week-old wt, lepr db/db , and lepr s/s mice using a radiotelemetry system. 20 Mice of each genotype were instrumented with radiotelemetric monitoring devices, which allowed continuous nonrestrained monitoring of blood pressure. A transmitter catheter (Data Sciences) was inserted into the left carotid artery when the mouse was under isoflurane anesthesia, and the blood pressure transmitter body (Data Science, PA-C20) was routed to the abdominal cavity. After recovery, the mouse was housed in an individual cage and provided with regular mouse chow and tap water ad libitum. Mean arterial pressure was recorded at 5-minute intervals for at least 2 weeks duration. After data collection, the 5 minute sampling periods were averaged over 5 consecutive days (once diurnal rhythm was established). The 5 minute averages were then furthered condensed into 24 separate 1 hour values for each hour during the entire light-dark cycle for the purpose of graphical presentation and statistical analysis.
Cell Culture
VSMC were isolated from 7 to 14 week-old wt, lepr db/db , and lepr s/s mice (nϭ3 each group) as previously described. 21 Cells were grown in Dulbecco modified Eagle medium (DMEM, Gibco Inc) containing 10% fetal bovine serum (FBS, Gibco Inc) and 1% penicillin/streptomycin, and passaged as described previously. 22 For experiments, cells between passages 4 and 9 were made quiescent by incubation with serum-free DMEM for 30 hours before use. The VSMC proliferation assay 6 and quantification of cell number by crystal violet staining and optical density reading 23 were performed as previously described. Briefly, cells were seeded in 96-well plate in DMEM containing 0.5% FBS at a density of 4ϫ10 3 /well and allowed to attach overnight. Medium was then replaced with DMEM containing 2% FBS and Insulin-TransferrinSelenium premix (Gibco Inc) in the presence of either leptin (100 ng/mL; R&D Systems) or vehicle. After 3 days of incubation, cells were fixed with 10% glutaraldehyde, stained with 0.1% crystal violet solution, and dissolved with 10% acetic acid. The wells were read at 590 nm in a microplate reader (VersaMax, Molecular Devices Corp). All assays were performed in triplicate wells and 2 to 3 replications of the experiment were performed.
Statistical Analysis
Values are expressed as meanϮSEM. The statistical significance of differences between groups was determined by 1-way ANOVA followed by Dunn post-hoc analysis when more than 2 experimental groups were included. The student 2-tailed t test was performed when only 2 groups were being compared. For BMT and blood pressure measurements, a 2-way analysis of variance was performed followed by the Tukey HSD test to examine significant main effects. PϽ0.05 was considered significant.
Results

Effect of Leptin and Leptin Receptor on Neointimal Formation
To determine the influence of leptin and the leptin receptor on neointimal formation, femoral injury was induced in wt, lep ob/ob , and lepr db/db mice. Four weeks after injury, the average femoral artery neointimal area and ratio of intima/media in lep ob/ob and lepr db/db mice was significantly reduced compared with wt mice (Figure 1 and Table 1 ). There were no differences in the medial area between wt, lep ob/ob , and lepr db/db . The neointimal area was comprised predominantly of VSMCs ( Figure 1 ). The VSMC cellular proliferation index was significantly reduced in lep ob/ob and lepr db/db compared with wt mice (Table 1) .
Effect of Exogenous Leptin on Neointimal Formation
To further examine whether the reduced neointimal formation in lep ob/ob mice was attributable to the lack of leptin, recombinant murine leptin was given to lep ob/ob mice beginning 1 day before injury on a daily basis until sacrifice. Leptin levels 12 hours after injection were 45.7Ϯ5.8 ng/mL compared with basal levels of 1.0Ϯ0.1 ng/mL in wt mice. The average neointima of lep ob/ob mice receiving recombinant leptin was significantly higher than lep ob/ob mice receiving no treatment ( Figure 1 ). These results confirm that leptin plays a causal role in neointimal growth.
To (Figure 1 ). The neointima of lep ob/ob mice receiving a control adenovirus was not different from lep ob/ob mice receiving no treatment (data not shown). This data supports the effect of leptin on neointimal formation and also demonstrates that leptin is not required at the time of injury to promote neointimal formation. The neointima of lepr db/db mice receiving ad-leptin was also examined to confirm the effects of the leptin receptor on neointimal formation and to serve as a control for nonspecific inflammatory effects of the adenovirus. The neointima of lepr db/db mice treated with ad-leptin was not different from the lepr db/db mice receiving no treatment (Figure 1 ).
Effect of Leptin Treatment on Body Weight and Metabolic Parameters
Leptin treatment improved many metabolic parameters in lep ob/ob mice ( Table 2) providing evidence of an improvement in the concentration of many classic risk factors. Despite these salient changes, there was a robust leptin-mediated enhancement of neointimal growth.
Effect of Bone Marrow Transplantation on Neointima Formation
To examine whether the leptin receptor-deficient phenotype was attributable to the lack of leptin receptor on circulating blood elements, BMT was performed from lepr db/db to wt, wt to wt, wt to lepr db/db , and lepr db/db to lepr db/db mice. Control mice not receiving bone marrow after irradiation died 7 days later, demonstrating effective bone marrow ablation after the irradiation. Six weeks after BMT, femoral arterial injury was performed to induce intimal hyperplasia. The neointima of wt mice receiving bone marrow from lepr db/db mice was significantly greater than that of lepr db/db mice receiving bone marrow from lepr db/db mice (Figure 2) . Similarly, the neoin- tima of lepr db/db mice receiving wt bone marrow was significantly less than the neointima observed in wt mice receiving bone marrow from wt mice (Figure 2 ).
Effect of LepR-Mediated STAT3 Signaling on Neointima Formation
To determine the effect of leptin receptor-STAT3 signaling on neointimal formation, lepr s/s mice (nϭ9), underwent femoral arterial injury. Despite development of an obese phenotype similar to that observed in lepr db/db mice ( Figure 3a through 3c).
Effect of LepR-Mediated STAT3 Signaling on Arterial Blood Pressure
To examine whether the neointimal formation of the lepr s/s was related to arterial blood pressure we measured the mean arterial pressure of wt, lepr db/db , and lepr s/s mice. Consistent with previous studies using radiotelemetry, we detected a reduced arterial pressure in lepr db/db compared with wild-type mice. 24 Similarly, the lepr s/s were observed to have reduced blood pressure compared with wild-type (Figure 4) . No difference in blood pressure was observed between lepr s/s and 
Effect of Leptin on SMC Proliferation
To further elucidate relevant signaling pathways, VSMCs were isolated from wt, lepr s/s , and lepr db/db mice. Similar to previous studies, 6 leptin induced a significant increase in cellular proliferation in wt cells compared with vehicle (leptinϭ0.40Ϯ0.006 versus vehicleϭ0.37Ϯ0.005; PϽ0.03). As previously shown, 6 this leptin effect was completely blocked with the phosphoinositide 3 kinase inhibitor, wortmannin (leptin ϩ wortϭ0.37Ϯ0.006; PϽ0.02 compared with leptin ϩ vehicle). VSMCs from lepr s/s mice also responded to leptin with an increase in proliferation compared with vehicle control (leptinϭ0.67Ϯ0.01 versus vehicleϭ0.49Ϯ0.02, PϽ0.00001), and this effect was blocked with wortmannin (lepϩwortϭ0.53Ϯ0.001, PϽ0.00003). VSMCs from lepr db/db mice did not respond to leptin treatment.
Discussion
Leptin is a 16-kDa peptide hormone with structural features similar to those of the long-chain helical cytokine family. 1 The expression of receptors for leptin are ubiquitous, 25 indicating that leptin may affect multiple physiological processes. To determine the importance of leptin and the leptin receptor on neointimal hyperplasia, we performed femoral wire injury on wt, lep ob/ob , and lepr db/db mice. Consistent with previous studies, lep ob/ob and lepr db/db mice were protected from neointimal formation. 11, 12 Similar to the findings of Schafer et al, 11 who used an iron chloride model of carotid injury, we have shown that leptin treatment (recombinant murine leptin or ad-leptin) increases neointima in the leptin deficient mice but not in mice lacking the leptin receptor, confirming a causal role for leptin and the leptin receptor in neointimal formation. In addition, cell proliferation analyses revealed that lep ob/ob and lepr db/db mice had significantly less cellular proliferation in the femoral arterial wall after injury compared with wt mice. This suggests that leptin may augment VSMC proliferation after arterial injury. Previous studies have demonstrated leptin receptor expression by VSMCs after arterial injury, supporting a direct effect of leptin on vascular smooth muscle cells. 11, 12 In addition to a potential role of the VSMCs, we sought to directly examine the importance of bone marrow-derived leptin receptor in leptin-mediated effects on neointimal hyperplasia. For these studies, we performed femoral wire injury after BMT from lepr db/db to wt and from wt to lepr db/db mice. Interestingly, the recipient phenotype was unchanged in both of these experiments compared with control groups receiving marrow from genetically identical donors. This suggests that the in vivo effect of the platelet and leukocyte leptin receptor is negligible toward the response to vascular injury. Similar to other cytokine receptors, the leptin receptor signals by activating a Jak family tyrosine kinase (Jak2) that autophosphorylates numerous tyrosine residues and phosphorylates tyrosine residues (Tyr985 and Tyr1138) on the leptin receptor during leptin stimulation. Leptin can therefore signal through activation of several different receptormediated pathways. 13 The relevance of these pathways toward energy balance has been established by the analysis of mice in which the leptin receptor gene has been substituted by a mutant leptin receptor (leprS1138) containing a Tyr1138-Ser substitution that is defective in STAT3 binding. 16 These mice develop obesity similar to that observed in lepr db/db mice, although other phenotypes associated with leptin receptor deficiency are less affected indicating the relevance of other signaling pathways such as the IRS-protein-PI3 kinase pathway. 13 The pathways responsible for the vascular effects of leptin are unknown, although both STAT3 and PI3K lepr signaling pathways have been implicated in VSMC proliferation in vitro. 26, 27 To dissect these pathways in vivo, lepr s/s mice with defective STAT3 signaling were studied in the femoral arterial injury model. These mice developed an obese phenotype similar to that observed in the lepr db/db group, as previously described, 16 but they exhibited significantly greater intimal hyperplasia after arterial injury, suggesting that leptin receptor-mediated STAT3 signaling is not responsible for the leptin effect on neointimal formation after injury.
The robust effects of exogenous leptin in these experiments could be partially mediated by effects on arterial blood pressure. Leptin has been shown to influence sympathetic activation with elevations in blood pressure. 24, 28, 29 Furthermore, this effect on sympathetic activity appears to be centrally mediated and may not be subject to the same degree of leptin resistance as observed with leptin-receptor related feeding behavior. 30 To examine whether the in vivo effects observed in the lepr s/s mice were mediated by elevations in blood pressure, we performed radiotelemetry arterial blood pressure recordings. Consistent with previous publications we observed reduced blood pressure in lepr db/db mice. 24 In addition, the blood pressure of the lepr s/s mice was also lower than wt and was not different than lepr db/db mice. Therefore, although high doses of exogenous leptin probably elevated blood pressure at some time points in our exogenous leptin experiments, we have demonstrated that elevations in blood pressure are not mediating the increased neointimal response of the lepr s/s mice as compared with the lepr db/db mice. To further examine the potential underlying mechanism of the increased neointimal response of the lepr s/s compared with the lepr db/db , we used a cell culture system to examine VSMC proliferation. Leptin has previously been shown to stimulate proliferation of VSMCs in culture 6 and our in vivo studies demonstrated reduced intimal VSMC proliferation in leptin deficient and leptin receptor deficient mice. Therefore, we examined whether the lepr db/db and lepr s/s mice responded differently to recombinant leptin in vitro. VSMCs isolated and cultured from lepr db/db did not respond to leptin treatment whereas leptin significantly stimulated the proliferation of VSMCs isolated from lepr s/s mice, consistent with the in vivo phenotype. Furthermore, this leptin effect on lepr s/s VSMC's was completely blocked after incubation of the VSMCs with a PI3 kinase inhibitor, implicating this pathway in leptin receptor-mediated VSMC proliferation.
Limitations of this study include the supraphysiologic plasma concentrations of leptin obtained in the leptin replacement experiments. These experiments serve as proof of principle that leptin affects neointimal hyperplasia. The increased neointimal hyperplasia observed in the lepr s/s mice compared with the lepr db/db mice, where no exogenous leptin was added, demonstrates the potential of physiological elevations of leptin, as observed in obese states, to affect this vascular end point. An additional limitation of this study is lack of definitive proof of the relevant leptin receptor cellular pool. Although we have demonstrated that leptin effects on neointimal hyperplasia are at least partially independent of Lepr-STAT3 signaling, not dependent on blood pressure elevation, and independent of bone marrow-derived elements, it remains possible that other Lepr-mediated central nervous system pathways could influence vascular disease.
In conclusion, these data suggest that leptin enhances neointimal formation through an interaction with the leptin receptor resulting in smooth muscle cell proliferation. These effects are mediated by a leptin receptor signaling pathway that is distinct from the major pathway involved in energy balance. These findings suggest that it may be possible to design therapeutic agents capable of promoting the beneficial metabolic activities of leptin while avoiding the potential hazard of vascular complications.
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